Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (CRC 1192)
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 2 November 2020
Accepted: 19 March 2021
First Online: 27 April 2021
Declarations
:
: This article does not contain any studies with human participants or animals performed by any of the authors.
: Tobias B. Huber declares advisory activities for Alexion, AstraZeneca, Bayer, Boehringer-Ingelheim, DaVita, Deerfield, Fresenius Medical Care/Unicyte, Goldfinch, Mantra Bio, Novartis and Travere. All other authors declare no conflict of interest.